Results 61 to 70 of about 20,522 (204)

Stability Indicating Liquid Chromatographic Method for the Simultaneous Determination of Rosuvastatin and Ezetimibe from Pharmaceuticals and Biological Samples

open access: yesJournal of the Turkish Chemical Society, Section A: Chemistry, 2020
Fixed dose combinations of ezetimibe and rosuvastatin are well known to provide significantly superior efficacy to rosuvastatin alone in lowering total cholesterol, and triglyceride levels.
Sevinç KURBANOĞLU   +6 more
doaj  

Impact of Evolocumab on LDL‐Cholesterol and Cardiovascular Outcomes in Patients With Established CVD: Systematic Review and Meta‐Analysis

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
A systematic review and meta‐analysis of 9 randomised controlled trials (67,662 patients) found that evolocumab significantly improved lipid parameters and reduced major adverse cardiovascular events, myocardial infarction, and coronary revascularisation.
Anika Goel   +10 more
wiley   +1 more source

The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia

open access: yesLipids in Health and Disease, 2004
Elevated low-density lipoprotein (LDL)-cholesterol is associated with a significantly increased risk of coronary heart disease. Ezetimibe is the first member of a new class of selective cholesterol absorption inhibitors.
Suleiman Ehab S   +2 more
doaj   +1 more source

Efficacy and Safety of Enlicitide in Hypercholesterolemia: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
Enlicitide (MK‐0616), an oral macrocyclic peptidyl PCSK9 inhibitor, blocks the interaction between circulating PCSK9 and hepatic LDL receptors, enhancing LDL‐C clearance from the bloodstream. This systematic review and meta‐analysis of three randomized, double‐blind, placebo‐controlled trials (n = 3593) evaluated the efficacy and safety of enlicitide ...
Muhammad Farhan   +10 more
wiley   +1 more source

Longitudinal Changes in Stone Composition and Histopathological and Proteomic Characterization of a Matrix Stone: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Matrix stones are rare urinary calculi composed predominantly of organic matrix, with poorly understood pathogenesis. We herein report a case involving refractory matrix stones with longitudinal compositional changes and characterize the final specimen using histopathological and proteomic analyses. Case Presentation A 54‐year‐old
Yuki Hideo   +4 more
wiley   +1 more source

Old disease, new twist

open access: yesJournal of Hospital Medicine, Volume 21, Issue 11, Page 1305-1309, November 2026.
Abstract An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of
Hadi Roudsari   +4 more
wiley   +1 more source

Clinical efficacy and safety of Ezetimibe on major cardiovascular endpoints: systematic review and meta-analysis of randomized controlled trials.

open access: yesPLoS ONE, 2015
BackgroundRandomized clinical trials (RCTs) about Ezetimibe's efficacy on patient-oriented outcomes have given discordant results. The aim of this study was to determine the net effect of Ezetimibe and of the widely marketed combination, Ezetimibe ...
Alessandro Battaggia   +4 more
doaj   +1 more source

Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study

open access: yesLipids in Health and Disease, 2018
Background The utility of ezetimibe in preventing cardiovascular outcomes remains controversial. To guide future assessments of the effectiveness of ezetimibe in routine care, we evaluated how this medication has been prescribed to high-risk older adults
Kristin K. Clemens   +3 more
doaj   +1 more source

Ezetimibe inhibits the migration and invasion of triple‐negative breast cancer cells by targeting TGFβ2 and EMT

open access: yesFEBS Open Bio
The important role of cholesterol in tumor metastasis has been widely studied in recent years. Ezetimibe is currently the only selective cholesterol uptake inhibitor on the market.
Lingkai Kong   +6 more
doaj   +1 more source

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia

open access: yesLipids in Health and Disease, 2009
Background Ezetimibe (Zetia®) is a potent inhibitor of cholesterol absorption that has been approved for the treatment of hypercholesterolemia. Statin, an inhibitor of cholesterol synthesis, is the first-choice drug to reduce low-density lipoprotein ...
Aoyama Naoyoshi   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy